Piperazin-2-ylmethanol dihydrochloride is primarily used in pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting neurological and psychiatric disorders. Its structure is valuable in creating molecules that interact with receptors in the central nervous system, making it useful in the design of potential drugs for conditions like anxiety, depression, and schizophrenia. Additionally, it is employed in the preparation of compounds with antimicrobial and antiviral properties, contributing to the development of new therapeutic agents. Its role in medicinal chemistry underscores its importance in advancing drug discovery and treatment options.